<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Recash test site | Mcconnell Pugh | Activity</title>
	<link>https://recash.wpsoul.net/members/startstock7/activity/</link>
	<atom:link href="https://recash.wpsoul.net/members/startstock7/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Mcconnell Pugh.</description>
	<lastBuildDate>Mon, 18 May 2026 15:33:57 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">a96aa783bfc4bb8c7cd93bbe0af127ef</guid>
				<title>Mcconnell Pugh posted an update: Finally, both in vitro toxicity assay and in vivo anti-cancer [&#133;]</title>
				<link>https://recash.wpsoul.net/activity/p/50657/</link>
				<pubDate>Wed, 11 Dec 2024 13:36:19 +0000</pubDate>

									<content:encoded><![CDATA[<p>Finally, both in vitro toxicity assay and in vivo anti-cancer efficacy study in TNBC xenograft models showed that the constructed ADC significantly inhibited TNBC growth, and the pharmacokinetics study indicated its high circulation stability. This study indicated that the anti-EGFR ADC has a great potential to against TNBC.Despite being an&hellip;<span class="activity-read-more" id="activity-read-more-50657"><a href="https://recash.wpsoul.net/activity/p/50657/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">a68a0bc41007dd9aaefe1124cbca2fe6</guid>
				<title>Mcconnell Pugh became a registered member</title>
				<link>https://recash.wpsoul.net/activity/p/50428/</link>
				<pubDate>Wed, 11 Dec 2024 13:13:38 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>